Windtree Therapeutics, Inc. WINT
0.00
0.00
NaN
as of 25 Sep
- Market cap
- $2.4M
- P/E
- 0.0×
Follow WINT
| Sep '25 | Jun '25 | Mar '25 | Dec '24 | Older periods | |
|---|---|---|---|---|---|
| 1,356.23% | (666.00%) | (161.40%) | (81.98%) |
+8 more TTM periods Free account |
|
| (210.34%) | (78.12%) | (72.97%) | (18.20%) | ||
ROIC |
(386.34%) | (103.49%) | (167.12%) | (178.02%) | |
Return on Tangible Assets |
333.66% | 266.88% | 433.35% | 180.97% | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(0.57) | (3.11) | (13.65) | (293.04) | |
Free Cash Flow |
(15.12) | (15.19) | (14.86) | (15.41) | |
Capital Expenditures |
— | — | — | (0.01) | |
| Other line items | |||||
Cash ROIC |
(259.50%) | (129.99%) | (123.81%) | (120.94%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.08) | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.31 | 0.64 | 0.72 | 2.81 | |
Depreciation/Fixed assets |
9.87 | 1.43 | 1.88 | 1.63 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | (0.07) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.57) | (3.11) | (13.65) | (292.81) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.23) | |
Capex to Sales |
— | — | — | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates